Mick Sehgal

A multifaceted executive with both domestic and global experience, Mick Sehgal has a proven track record in profit and loss management, information technology project management, operations assessment, risk analysis, business process reengineering, business case analysis, mergers/acquisitions and strategic planning. Mick has more than 20 years’ experience, starting at AT&T, where over a seven-year career he held positions as operations manager, senior Auditor and senior consultant. Before joining Sequent, he was CFO and a member of the board of directors at Hamilton Scientific, an e-health company. Mick has also been the CEO of Frontier Metals, a multinational metal trading company. At Sequent, Mick has delivered more than 50 IT projects in five years to mid-capital and Fortune 500 companies. Projects range from business intelligence management dashboards to enterprise resource planning (ERP) implementations. He is a frequent speaker on business intelligence (BI) and data warehousing at such forums as New Jersey Technology Council and the New Jersey Institute of Technology. He has an M.S. in applied statistics and an M.B.A. in finance from the University of North Carolina. His B.S. is in mechanical engineering from MSU, one of India’s major universities.

CJ Singh

CJ is a seasoned technology professional with extensive business experience and development focused on end users. He has led teams on numerous cross-functional projects in a broad range of industries, including total lifecycle software development; system architecture, design and development; and. data integration projects using the latest software development tools and techniques. His superior command of numerous front- and back-end languages makes him an exceptional leader for any technology business solution project. CJ was a technical manager and team leader for Omnipoint, a pioneer and leading provider of GSM-based mobile phone services. The company has since merged with Voicestream Wireless and T-Mobile. At Sequent, CJ has been lead solution designer system integrator for numerous clients, including Novartis, Englert, Inc., New Jersey Sports Authority-Meadowlands Racetrack; Voicestream Wireless; Easylink Services, Expo Electronics and 6th Avenue Electronics. CJ has an M.B.A. with a focus on information technology from Rutgers Business School. He graduated summa cum laude from the New Jersey Institute of Technology.

Steven Harwood

Originally from New York, Steven Harwood holds a BA degree in Latin American Studies from the Univ. of Albany and an MBA in International Business from the State Univ. of New York at Binghamton. Mr. Harwood entered the pharmaceutical field in the early 80’s with Ayerst/Wyeth where he served as Promotion Manager -International and Regional Manager — Asia/Pacific. He then spent 3 years based in India with Farmitalia Carlo Erba (ultimately acquired by Pfizer) where he set up a new pharmaceutical operation, and 2 years in Taiwan as General Manager for Sanofi (Sanofi-Aventis). After a 5-year stint as an independent consultant, which included lecturing on International Business at SUNY Binghamton’s MBA program, Mr. Harwood was hired as Regional Director-Latin America for Nycomed/Amersham, a company subsequently acquired by GE Healthcare. Following 5 years with GE Healthcare, at the end of 2008 Mr. Harwood created Latin Nexus, LLC based in Miami, Florida to promote health care initiatives between Latin America and other global markets. Mr. Harwood is proficient in 7 languages including English, Spanish, Portuguese, French, Italian, Mandarin Chinese and Hindi.

Holger Meissner

Holger Meissner is the founder and owner of Adler Life Sciences, LLC a boutique business and competitive intelligence firm for the Life Science Industry located in New Jersey. Adler’s business mission is to help its clients make timelier, more informed and smarter business decisions that help their companies “win” in an intensely competitive business environment. Prior to founding Adler Life Sciences in 2007, Holger was the Head of the Global Competitive Intelligence at Bayer HealthCare Consumer Care Division in Morristown, New Jersey. He joined the Bayer Group in 1985. Throughout his years at Bayer, he held positions of increasing responsibility in local, regional and global marketing functions for the Consumer Care Division, managing brands such as Bayer Aspirin, Alka-Seltzer, and Canesten. During this time he worked in various countries such as Germany, Colombia, South Korea, Japan, Singapore, Hong Kong and China.

John J. Trombetta

Overview
Over thirty years of diverse experience in the pharmaceutical industry, including quality assurance, long range forecasting, business and strategic planning, corporate and business development (including numerous product and company licensing and acquisition opportunity evaluations), marketing research, and marketing management.

Education and Experience
Mr. Trombetta has over thirty years of diverse experience in the pharmaceutical industry, including quality assurance, long range forecasting, business and strategic planning, corporate and business development (including numerous product and company licensing and acquisition opportunity evaluations), marketing research, and marketing management.

After graduation from LaSalle College with a BA in Chemistry, he received his MBA from Widener University in 1972 and a year later joined Stuart Pharmaceuticals (now AstraZeneca Pharmaceuticals) in Quality Assurance. In this position he developed and implemented a control chart program; a computerized storage and retrieval system for product release data; a vendor assurance program; a product complaint classification and reporting system and a product complaint tracking system.

In 1983 Mr. Trombetta joined Berlex Laboratories as Manager, Business Development & Strategic Planning where he assisted the Executive Committee in establishing corporate objectives and in developing a medium range business plan. In 1984, Mr. Trombetta was selected to assume the position of Manager, Marketing Research Pharmaceuticals and to build a team that would provide a balanced program of primary and secondary market research for the pharmaceutical market area.

In 1996 as Director, Corporate Development, Mr. Trombetta assisted the CEO and the Executive Committee in the management of Berlex’s strategic corporate alliances

From 1997 through 1999, Mr. Trombetta was Director of Business Development and Market Research for the Female Healthcare strategic unit of Berlex Laboratories

Most recently, Mr. Trombetta was a Senior Vice President of Thomson Physicians World and was responsible for managing and directing the operations of a market research division (Thomson Advanced Health Market Research)

In 2003, Mr. Trombetta started his own consulting firm, TRA, LLC. Mr. Trombetta provides consulting services to the healthcare, pharmaceutical, and diagnostic imaging industries utilizing his over thirty years of extensive marketing and market research experience.

Bill Sammon

Bill Sammon is a principal at Decision Intelligence Inc. (DII), an independent strategy and research consulting firm he founded in 2009 located in Cold Spring, NY. DII collaborates with consulting firms on corporate, business unit, and product line projects designed to assist clients in developing strategic, business development, marketing, R&D, manufacturing, and investor relations decisions.

Bill began working in the pharmaceutical industry when he joined Pfizer Inc’s Corporate Strategic Planning Department in 1982 as a senior analyst. Prior to that, he served 11 years in U.S. Army intelligence assignments (1968-1979) and spent three years at International Paper in strategic planning where he founded that corporation’s competitive intelligence department. From 1987 to 1990, he worked at two Wall Street brokerage firms (Mabon Nugent and Wood Gundy) as a sell-side pharmaceutical industry analyst. In 1990, he returned to Pfizer as Director Planning, US pharmaceutical operations.

In May 2008, Bill retired from Pfizer after 23 years of service in various strategic planning, business development and investor relations senior staff positions. In his last position, he served as Senior Director, Strategic Information and Analysis, Investor Development, Corporate Finance. His principal responsibilities included: 1) supervising strategic intelligence studies assessing competitive threats and strategic opportunities, 2) providing strategic intelligence to senior corporate executives, 3) providing intelligence on competitor institutional investors and competitors’ investor relations strategies, and 4) leading Pfizer’s Corporate Business Intelligence Advisory Group which led product marketing teams and business units in the development and management of internal and external business and competitive intelligence assets.

Bill is the editor and author of Business Competitor Intelligence, (John Wiley & Sons, 1984) and contributed a chapter on strategic business intelligence to the Handbook of Strategic Planning, (John Wiley & Sons, 1986). He earned a BA in political science from Boston College (1964), an MA in political science from the University of Chicago (1975), and an MA in finance from Long Island University (1979). Bill is a graduate of the U.S. Army’s Military Intelligence Schools and the Command and General Staff College (1987). He retired from the U.S. Army Reserve in 1996 as a Lieutenant Colonel after 28 years of service.

Mark L. Horn MD, MPH

Mark L. Horn MD, MPH is a Board Certified Internist and Rheumatologist with over twenty years of experience in the large Pharmaceutical Industry. In 2008 he founded MedaConsults LLC, a Health Policy, Medical & Scientific Consulting Firm based in New Jersey. He currently serves as a Principal Consultant in that Firm, as the Chief Medical Officer of Target Health, Inc. a Clinical Research Organization based in New York City and as a Senior Advisor to Avalere Health, a health policy consulting firm based in Washington, DC.

During a 25 year career at Pfizer, Dr. Horn managed development programs in multiple clinical disciplines, among them arthritis & inflammation and cardiovascular diseases, including hypertension and angina. In addition, during his tenure at Pfizer he led teams in Licensing & Development, Medical Marketing in multiple therapeutic areas, and Worldwide Public Affairs and Policy.

Dr. Horn retired from Pfizer Inc following several years’ leadership of the Worldwide Medical Policy and Evidence Based Medicine/Health Technology Assessment Teams. These groups were responsible for crafting strategies to address the increasingly complex, often cost driven, globally diverse requirements for clinical and economic data to support reimbursement of prescription medicines by public and private payers. The groups were also responsible for both portfolio and product strategies responsive to the array of health reform initiatives, among them insurance reform & benefit design, pay for performance, quality initiatives (including physician economic rankings), and (CMS driven) coverage with evidence development programs, anticipated in the United States.

In addition to his MD (New York University) and undergraduate (Brown) degrees, Dr. Horn holds an MPH degree in Health Policy and Management (Columbia).

Dr. Horn serves on the voluntary clinical faculty of the Mount Sinai Hospital and School of Medicine in New York City, is a current member of the US Pharmacopoeia Safe Medication Use Expert Committee and served on the US Pharmacopoeia Medicare Model Guidelines Expert Committee. He served for over a decade on the American Medical Association Continuing Medical Education Task Force on Provider/Industry/Academic Collaboration. He is a member of the American Medical Association and a Fellow of the American College of Rheumatology and is Board Certified in Internal Medicine and Rheumatology.

During 2009 Dr. Horn has addressed the State Senate Presidents’ Forum, the Western Pain Society Annual Meeting and the National Pain Week meeting on the implications of Health System Reform for patient care. He recently delivered the Keynote Address at the New Jersey Technology Council Forum e-Summit examining the role of Electronic Health Records in clinical care.

Thomas Prendergast, MD

Dr. Prendergast is an actively practicing Cardiothoracic Surgeon in New Brunswick, New Jersey, USA. His responsibilities include clinical and research activities, as well as electronic medical recording (EMR).

Dr. Prendergast received a BS degree in Biophysics and a BS in Psychology from Pennsylvania State University. He also received his MD degree from Penn State, Hershey Campus. His general surgery training included five years at University of Massachusetts Medical School and Cardiothoracic Surgery training at LA County/University of Southern California Medical School. Subsequent fellowship training in Pediatric Cardiothoracic Surgery was at Children's Hospital Los Angeles along with Heart and Lung Transplantation fellowships at both University of Southern California and Temple University Hospital in Philadelphia. He spent three years at University of Kansas Medical School as Director of Congenital Cardiothoracic Surgery and responsibilities included reestablishing heart and lung transplant programs. After two more years at Temple University Hospital, he joined up with Newark Beth Israel/St. Barnabas Hospital in New Jersey, where he eventually assumed responsibility for the Heart Transplant directorship. He is presently at Robert Wood Johnson University Hospital (RWJUH) as part of the University of Medicine and Dentistry of New Jersey (UMDNJ), where he is a busy cardiac surgery practitioner performing 200-250 open heart operations per year. He is presently the Surgical Director of Cardiac Transplantation and Ventricular Assistance at RWJUH and holds an Associate Professor of Surgery position at the UMDNJ.

In addition to being an active participant in stem cell research program development, he has spent a great deal of time in EMR development. Business interests include medical research funding, real estate development and humanitarian development for American Veterans. He presently resides in Berkeley Heights, New Jersey with his wife and daughter.

Dr. Frederic J. Vagnini

Dr. Frederic J. Vagnini is one of the most unique physicians and health educators in the world. After graduation from St. Louis University School of Medicine in 1963, Dr. Vagnini underwent 8 years of post doctorate internship and residency. These years studying surgery, vascular, heart and lung surgery were spent at the Downstate Medical Center, Brooklyn, New York and Columbia Presbyterian Medical Center, New York. Following completion of training Dr. Vagnini served in the United States Army as a Lieutenant Colonel and subsequently entered into private practice on Long Island, New York. For the next 25 years Dr. Vagnini practiced as a heart, lung and blood vessel surgeon. He has operated on thousands of patients with heart and blood vessel disease. As his career continued Dr. Vagnini became interested in Health Education, Preventive Medicine and Clinical Nutrition. Because of his vast experience in the area of heart disease and nutrition he became a frequent guest speaker and has appeared numerous times on local and national radio and television.

Dr. Vagnini has extensive media experience with hundreds of radio and television appearances. He presently hosts a live call in show on WOR 710 AM. The show is called "The Heart Show" and airs from 4-5 PM Sundays. Dr. Vagnini formerly hosted a national health show on Fox Television.